Power Law company profile

Denali Therapeutics

Biotech & Life Sciences · South San Francisco, United States · Founded 2015 · IPO 2017 Unicorn

Discover and develop medicines to defeat neurodegeneration

Valuation

$1.51B

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

9 investors on Denali Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 6 investors entered at this stage

Biomatics Capital Partners

Eight Roads Ventures

ARCH Venture Partners

F-Prime

Flagship Pioneering

Alaska Permanent Fund

Series B+ 3 investors entered at this stage

Foresite Capital

Baillie Gifford

University Of Houston

Global footprint

Where Denali Therapeutics has talent and traffic

AI talent share

1.6% of workforce is AI talent
(9 of 568 staff)

Core AI20.35%

Other AI71.23%

Non-AI workforce55998.42%

Workforce by country

6 countries with
team presence

🇺🇸 United States95.6%

🇨🇭 Switzerland3.6%

🇪🇸 Spain0.2%

🇮🇹 Italy0.2%

🇹🇷 Turkey0.2%

Top 5 of 6 shown

Web traffic by country

35K monthly visits
across markets

🇺🇸 United States56.6%

🇯🇵 Japan15.7%

🏳️ Korea12%

🏳️ Republic of4.6%

🇨🇭 Switzerland3.1%

Top 5 markets shown

Patent intelligence

$92M patent portfolio · 111 active families

Estimated portfolio value

$92M

6.1% of market cap · 22× smaller than top peer Ablynx ($2B)

111 active patent families

Where Denali Therapeutics innovates Molecular biologyProdrugStereoisomerismCell biologyPharmaceutical medicine

Where Denali Therapeutics concentrates vs peers

Each axis is a top-10 topic across Denali Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Denali Therapeutics

An AI-synthesized read of the highest-engagement posts about Denali Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Denali Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles